Biechele Royce Advisors Sanofi Transaction History

Biechele Royce Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 16, 2019	SELL	$40.43 - $44.3 $1.57 Million - $1.72 Million	-38,773 Closed	0 $0
Q1 2019 Apr 17, 2019	SELL	$40.83 - $45.43 $61,367 - $68,281	-1,503 Reduced 3.73%	38,773 $1.72 Million
Q4 2018 Feb 05, 2019	SELL	$41.48 - $45.59 $45,752 - $50,285	-1,103 Reduced 2.67%	40,276 $1.75 Million
Q3 2018 Oct 30, 2018	SELL	$40.0 - $44.84 $2.44 Million - $2.74 Million	-61,053 Reduced 59.6%	41,379 $1.85 Million
Q2 2018 Jul 20, 2018	BUY	$37.63 - $41.22 $2.59 Million - $2.84 Million	68,843 Added 204.96%	102,432 $6.87 Million
Q1 2018 Apr 20, 2018	BUY	$38.98 - $45.76 $2,299 - $2,699	59 Added 0.18%	33,589 $1.35 Million
Q4 2017 Feb 08, 2018	BUY	$42.86 - $50.61 $1.44 Million - $1.7 Million	33,530	33,530 $1.44 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $123B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Biechele Royce Advisors, based on Form 13F filings with the SEC.

Stay updated on Biechele Royce Advisors with notifications on news.